论文部分内容阅读
本研究旨在探讨Ki－67LI与膀胱癌临床病理特征及预后的关系，以明确Ki-67免疫组化检测的临床应用价值。一、材料及方法选用1993年至1995年间因原发性膀优癌行膀优镜活检、经尿道电切。膀胱部分切除和膀胱全切除的肿瘤标本45例。其中男37例，女8例，年龄33～79岁，平均56.4岁。
The purpose of this study was to investigate the relationship between Ki-67LI and the clinicopathological features and prognosis of bladder cancer in order to clarify the clinical value of Ki-67 immunohistochemistry. First, the material and methods selected from 1993 to 1995 due to primary bladder cancer gifted biopsy biopsy, transurethral resection. Partial resection of the bladder and bladder resection of tumor specimens in 45 cases. Including 37 males and 8 females, aged 33 to 79 years, mean 56.4 years.